Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Connective tissue activation. IX. Modification by pharmacologic agents.

C W Castor

    Arthritis and Rheumatism
    |September 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Arthritis and Aerobic Exercise: A Review.

    The Physician and sportsmedicine·2016
    Same author

    Connective tissue activation. XXXVII. Effects of cytokine combinations, implications for an integrated cytokine network.

    The Journal of rheumatology·1998
    Same author

    Connective tissue activating peptide-V and CD59: a molecule in search of a job.

    The Journal of rheumatology·1996
    Same author

    Connective tissue activation. XXXVI. The origin, variety, distribution, and biologic fate of connective tissue activating peptide-III isoforms: characteristics in patients with rheumatic, renal, and arterial disease.

    Arthritis and rheumatism·1993
    Same author

    Regulation of glucose transporters by connective tissue activating peptide-III isoforms.

    The Journal of biological chemistry·1992
    Same author

    Connective tissue activation. XXXV. Detection of connective tissue activating peptide-III isoforms in synovium from osteoarthritis and rheumatoid arthritis patients: patterns of interaction with other synovial cytokines in cell culture.

    Arthritis and rheumatism·1992
    Same journal

    Proceedings of the Annual Meeting of the American Rheumatism Association.

    Arthritis and rheumatism·2020
    Same journal

    The regional distribution of rheumatologists: what can we do, what should we do?

    Arthritis and rheumatism·2013
    Same journal

    Regional distribution of adult rheumatologists.

    Arthritis and rheumatism·2013
    Same journal

    Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome.

    Arthritis and rheumatism·2013
    Same journal

    Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.

    Arthritis and rheumatism·2013
    Same journal

    Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.

    Arthritis and rheumatism·2013
    See all related articles

    Alpha- and beta-adrenergic blocking agents and imipramine reduce hyaluronate synthesis stimulated by connective tissue activating peptide (CTAP). These drugs may work through membrane stabilization, not traditional receptor blockade, suggesting novel therapeutic approaches.

    Area of Science:

    • Biochemistry
    • Pharmacology
    • Rheumatology

    Background:

    • Connective tissue activating peptide (CTAP) can increase hyaluronate synthesis in human synovial cultures.
    • Understanding the mechanisms that regulate hyaluronate synthesis is crucial for treating conditions involving connective tissue.

    Purpose of the Study:

    • To investigate the inhibitory effects of alpha- and beta-adrenergic blocking agents and imipramine on CTAP-induced hyaluronate synthesis.
    • To explore the potential mechanisms of action for these inhibitory agents.

    Main Methods:

    • Human synovial cultures were utilized to study hyaluronate synthesis.
    • The effects of various drug concentrations and analogues on CTAP-induced responses were assessed.
    • Time-course studies were performed to elucidate the kinetics of inhibition.

    Related Experiment Videos

    Main Results:

    • Alpha- and beta-adrenergic blocking agents and imipramine demonstrated inhibitory effects on CTAP-induced hyaluronate synthesis.
    • Drug concentration and analogue studies suggested that the inhibitory action was not mediated by conventional alpha or beta receptor blockade.
    • Ethacrynic acid showed potent and more complete inhibition, indicating a distinct mechanism.

    Conclusions:

    • The "antiactivation" effect of adrenergic blockers and imipramine may be linked to their membrane-stabilizing properties rather than direct receptor antagonism.
    • Ethacrynic acid acts through a separate pathway, highlighting the complexity of regulating connective tissue activation.